Binding and neutralization efficiencies of monoclonal antibodies, Fab fragments, and scFv specific for L1 epitopes on the capsid of infectious HPV particles

被引:43
作者
Culp, Timothy D. [1 ]
Spatz, Christin M. [1 ]
Reed, Cynthia A. [1 ]
Christensen, Neil D. [1 ]
机构
[1] Penn State Univ, Gittlen Canc Res Fdn, Hershey, PA 17033 USA
关键词
human pap ilomavirus; HPV-11; HPV-16; monoclonal antibodies; fab fragments; single-chain variable fragments (scFv); virus neutralization; viral epitopes; vaccine; pseudovirus; vinis like particles (VLPs);
D O I
10.1016/j.virol.2006.12.002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We compared the neutralization abilities of individual monoclonal antibodies (MAb) of two large panels reactive with L I epitopes of HPV-11 or HPV-16. Binding titers were compared using both L1-only VLPs and L1/L2 pseudovirions. While the VLPs were antigenically similar to the pseudovirions, clear differences in the surface exposure of some epitopes were evident with the HPV-16 particles. To determine whether all antibody binding events are equivalent in their neutralizing effect on infectious HPV virions or pseudovirions, the binding and neutralization titers for individual MAbs were used to calculate the relative neutralization efficiency for each antibody. HPV neutralization was achieved by all MAbs capable of strong binding to either linear or conformation-sensitive epitopes on pseudovirus particles. Our data suggest, however, that some L1 epitopes may be more neutralization-sensitive than other surface epitopes, in that successful infection can be blocked by varying degrees of epitope saturation. Additionally, the effective neutralization of virions by several monovalent Fab fragments and single-chain variable fragments (scFv) demonstrates that viral neutralization does not require HPV particle aggregation or L1 crosslinking. Identification of capsid protein structures rich in neuralization-sensitive epitopes may aid in the development of improved recombinant vaccines capable of eliciting effective and long-term antibody-mediated protection against multiple HPV types. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:435 / 446
页数:12
相关论文
共 47 条
[1]  
Billich Andreas, 2003, Curr Opin Investig Drugs, V4, P210
[2]   Two antibodies that neutralize papillomavirus by different mechanisms show distinct binding patterns at 13 Å resolution [J].
Booy, FP ;
Roden, RBS ;
Greenstone, HL ;
Schiller, JT ;
Trus, BL .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 281 (01) :95-106
[3]   IMMUNIZATION WITH VIRUS-LIKE PARTICLES FROM COTTONTAIL RABBIT PAPILLOMAVIRUS (CRPV) CAN PROTECT AGAINST EXPERIMENTAL CRPV INFECTION [J].
BREITBURD, F ;
KIRNBAUER, R ;
HUBBERT, NL ;
NONNENMACHER, B ;
TRINDINHDESMARQUET, C ;
ORTH, G ;
SCHILLER, JT ;
LOWY, DR .
JOURNAL OF VIROLOGY, 1995, 69 (06) :3959-3963
[4]   Efficient intracellular assembly of papillomaviral vectors [J].
Buck, CB ;
Pastrana, DV ;
Lowy, DR ;
Schiller, JT .
JOURNAL OF VIROLOGY, 2004, 78 (02) :751-757
[5]   Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1 [J].
Carter, JJ ;
Wipf, GC ;
Benki, SF ;
Christensen, ND ;
Galloway, DA .
JOURNAL OF VIROLOGY, 2003, 77 (21) :11625-11632
[6]   Identification of human papillomavirus type 16 L1 surface loops required for neutralization by human sera [J].
Carter, Joseph J. ;
Wipf, Greg C. ;
Madeleine, Margaret M. ;
Schwartz, Stephen M. ;
Koutsky, Laura A. ;
Galloway, Denise A. .
JOURNAL OF VIROLOGY, 2006, 80 (10) :4664-4672
[7]   Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16 [J].
Chen, XJS ;
Garcea, RL ;
Goldberg, I ;
Casini, G ;
Harrison, SC .
MOLECULAR CELL, 2000, 5 (03) :557-567
[8]   MONOCLONAL ANTIBODY-MEDIATED NEUTRALIZATION OF INFECTIOUS HUMAN PAPILLOMAVIRUS TYPE-11 [J].
CHRISTENSEN, ND ;
KREIDER, JW ;
CLADEL, NM ;
PATRICK, SD ;
WELSH, PA .
JOURNAL OF VIROLOGY, 1990, 64 (11) :5678-5681
[9]   Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types [J].
Christensen, ND ;
Cladel, NM ;
Reed, CA ;
Budgeon, LR ;
Embers, ME ;
Skulsky, DM ;
McClements, WL ;
Ludmerer, SW ;
Jansen, KU .
VIROLOGY, 2001, 291 (02) :324-334
[10]   Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus [J].
Christensen, ND ;
Reed, CA ;
Cladel, NM ;
Han, R ;
Kreider, JW .
JOURNAL OF VIROLOGY, 1996, 70 (02) :960-965